Analysts predict that Addus Homecare Co. (NASDAQ:ADUS) will post $0.51 earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have made estimates for Addus Homecare’s earnings. The lowest EPS estimate is $0.41 and the highest is $0.56. Addus Homecare reported earnings per share of $0.46 during the same quarter last year, which suggests a positive year-over-year growth rate of 10.9%. The company is expected to issue its next quarterly earnings results on Monday, March 4th.
According to Zacks, analysts expect that Addus Homecare will report full-year earnings of $1.88 per share for the current year, with EPS estimates ranging from $1.72 to $2.01. For the next financial year, analysts forecast that the business will post earnings of $2.20 per share, with EPS estimates ranging from $1.79 to $2.54. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for Addus Homecare.
Addus Homecare (NASDAQ:ADUS) last announced its quarterly earnings results on Tuesday, November 6th. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.08. The business had revenue of $137.63 million for the quarter, compared to the consensus estimate of $139.43 million. Addus Homecare had a return on equity of 10.70% and a net margin of 3.25%.
ADUS has been the topic of several recent research reports. Robert W. Baird reissued a “hold” rating and issued a $65.00 price target on shares of Addus Homecare in a report on Wednesday, August 8th. ValuEngine raised Addus Homecare from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 4th. BidaskClub downgraded Addus Homecare from a “strong-buy” rating to a “buy” rating in a report on Friday, August 10th. Jefferies Financial Group assumed coverage on Addus Homecare in a report on Tuesday, August 21st. They issued a “buy” rating and a $75.00 price target on the stock. Finally, Oppenheimer lifted their target price on Addus Homecare from $50.00 to $72.00 and gave the company an “outperform” rating in a research note on Wednesday, August 8th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $73.50.
In related news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of Addus Homecare stock in a transaction on Monday, August 20th. The stock was sold at an average price of $59.00, for a total value of $60,459,247.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 34.80% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the stock. SG Americas Securities LLC acquired a new position in shares of Addus Homecare in the 2nd quarter worth $118,000. Paradigm Capital Management Inc. NY purchased a new position in shares of Addus Homecare during the second quarter valued at $2,558,000. Schwab Charles Investment Management Inc. grew its holdings in shares of Addus Homecare by 30.2% during the second quarter. Schwab Charles Investment Management Inc. now owns 16,279 shares of the company’s stock valued at $932,000 after buying an additional 3,779 shares in the last quarter. ClariVest Asset Management LLC purchased a new position in shares of Addus Homecare during the second quarter valued at $3,781,000. Finally, Northpointe Capital LLC purchased a new position in shares of Addus Homecare during the second quarter valued at $1,960,000. Institutional investors and hedge funds own 82.42% of the company’s stock.
Shares of NASDAQ ADUS traded up $0.15 during mid-day trading on Thursday, hitting $75.04. The company had a trading volume of 5,733 shares, compared to its average volume of 110,830. The company has a market cap of $889.87 million, a price-to-earnings ratio of 51.68, a price-to-earnings-growth ratio of 2.82 and a beta of -0.26. Addus Homecare has a 12 month low of $30.95 and a 12 month high of $74.97. The company has a current ratio of 3.09, a quick ratio of 3.09 and a debt-to-equity ratio of 0.53.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Featured Story: What are the components of an earnings report?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.